Chugai Phrma Stock Price, News & Analysis
Company Description
Chugai Phrma (OTC Link: CHGCY) is a publicly traded drug manufacturers - general company in the Healthcare sector. The company has a market capitalization of $74.6B.
CHGCY stock has declined 7.5% over the past year. Shares last traded at $27.22.
This page provides a comprehensive overview of CHGCY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chugai Phrma (CHGCY) stock last traded at $27.22, down 2.37% from the previous close. Over the past 12 months, the stock has lost 7.5%. At a market capitalization of $74.6B, CHGCY is classified as a large-cap stock with approximately 3.3B shares outstanding.
Latest News
Chugai Phrma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, partnership, clinical trial, conferences. View all CHGCY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Chugai Phrma (CHGCY) currently stands at 28.6 thousand shares, down 50.4% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 28.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Chugai Phrma (CHGCY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CHGCY Company Profile & Sector Positioning
Chugai Phrma (CHGCY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CHGCY often look at related companies in the same sector, including Daiichi Sankyo (DSNKY), Bayer Aktien (BAYRY), Bayer A G (BAYZF), Otsuka Holdings (OTSKY), and Otsuka Holdings (OTSKF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CHGCY's relative position within its industry.